These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9465851)

  • 21. [Calcium antagonists: first choice antihypertensive drugs].
    Zidek W
    Med Klin (Munich); 2005 Jun; 100(6):347-52; quiz 353-4. PubMed ID: 15968487
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure.
    Packer M; Miller AB
    Am J Cardiol; 1999 Aug; 84(4A):1L-2L. PubMed ID: 10480439
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of coronary heart disease with calcium antagonists in clinical practice].
    Bleifeld W; Spokojny A
    Med Welt; 1983 Nov; 34(47):1335-9. PubMed ID: 6656569
    [No Abstract]   [Full Text] [Related]  

  • 25. [The coronary hypertensive: therapeutic principles].
    Gosse P; Aouizerate E; Roudaut R; Dallocchio M
    Ann Cardiol Angeiol (Paris); 1986; 35(7):397-401. PubMed ID: 2879503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 27. [Leukocytoclastic vasculitis in relation to amlodipine administration].
    del Río Fernández MC; Plagaro Cordero ME; de Frutos Arribas JF; del Pozo Román T; Martín Escudero JC
    Rev Clin Esp; 1995 Oct; 195(10):738-9. PubMed ID: 8532938
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine Compared with Benidipine in the Management of Hypertension: A Systematic Review and Meta-Analysis.
    Sofy AA; Abdelsattar AT; Mohammed OM; Shareef MA; Alamodi AA; Nso N; Payton M; Masoud AT
    High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):527-537. PubMed ID: 33001356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bevacizumab-induced hypertension by amlodipine.
    Mir O; Coriat R; Ropert S; Cabanes L; Blanchet B; Camps S; Billemont B; Knebelmann B; Goldwasser F
    Invest New Drugs; 2012 Apr; 30(2):702-7. PubMed ID: 20878444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
    Hollenberg NK; Williams GH; Anderson R
    Arch Intern Med; 2000 May; 160(10):1477-83. PubMed ID: 10826461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pointers from recent multicentre trials using ambulatory monitoring--placing placebo in perspective.
    Mulcahy D
    Eur Heart J; 1995 Dec; 16(12):1754-6. PubMed ID: 8682000
    [No Abstract]   [Full Text] [Related]  

  • 33. [Calcium antagonist in heart failure. No improvement, no damage].
    MMW Fortschr Med; 2000 Mar; 142(13):6. PubMed ID: 10783614
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of hypertensive heart disease: vasodilator agents in the forefront].
    Bolli P; Bühler FR
    Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947
    [No Abstract]   [Full Text] [Related]  

  • 35. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X; Gong L; Guo J; Wang X; Liu Y; Ye X; Zhang G; Yang P
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension update for the 1980s.
    Lowenthal DT; Swartz CD
    Prim Care; 1985 Mar; 12(1):101-15. PubMed ID: 2859624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amlodipine-induced myoclonus.
    Wallace EL; Lingle K; Pierce D; Satko S
    Am J Med; 2009 Apr; 122(4):e7. PubMed ID: 19332219
    [No Abstract]   [Full Text] [Related]  

  • 38. Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications.
    Kalus JS; White CM
    Ann Pharmacother; 2002 Nov; 36(11):1759-66. PubMed ID: 12398574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amlodipin (Norvasc). A new calcium antagonist with long half-life].
    Thaulow E; Erikssen J; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1991 Jun; 111(16):1981-2. PubMed ID: 1830978
    [No Abstract]   [Full Text] [Related]  

  • 40. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L; Cardoni O; Fogari R; Innocenti P; Porcellati C; Provvidenza M; Meilenbrock S; Sullivan J; Bodin F
    Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.